TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Gland Pharma Ltd. ( (IN:GLAND) ).
Gland Pharma Limited has announced a significant change in its leadership structure. Effective January 16, 2025, Mr. Shyamakant Giri will take over as the Chief Executive Officer. Mr. Srinivas Sadu will continue his role as Executive Chairman, supporting the company’s future growth plans. This leadership transition indicates a strategic move to bolster Gland Pharma’s operations and growth trajectory, potentially impacting its market positioning positively.
More about Gland Pharma Ltd.
YTD Price Performance: -7.85%
Average Trading Volume: 12,481
Current Market Cap: 274.8B INR
For a thorough assessment of GLAND stock, go to TipRanks’ Stock Analysis page.